Candriam Equities L Oncology Impact PI/ LU1864483836 /
| NAV30/05/2024 | Var.+7.2200 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 2,487.4099USD | +0.29% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | - | 2.70 | -3.61 | -2.53 | 8.73 | 0.34 | -0.24 | -3.14 | 5.14 | 8.00 | 5.07 | - |
| 2020 | -1.43 | -5.31 | -3.03 | 12.16 | 8.58 | 1.46 | 4.47 | 2.19 | 3.55 | -2.17 | 5.86 | 3.90 | +33.03% |
| 2021 | 0.58 | -4.17 | -0.05 | 2.37 | 0.21 | 3.57 | -0.93 | 5.62 | -3.73 | 3.41 | -6.33 | 4.03 | +3.90% |
| 2022 | -10.46 | -1.72 | 4.69 | -5.82 | -1.29 | 0.08 | 4.40 | -3.10 | -4.68 | 7.08 | 6.11 | -3.41 | -9.27% |
| 2023 | 2.20 | -3.85 | 1.42 | 2.86 | -2.52 | 0.12 | 0.93 | -1.98 | -5.21 | -6.32 | 9.26 | 5.77 | +1.56% |
| 2024 | 1.41 | 4.18 | 1.53 | -3.34 | 1.83 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 10.74% | 11.05% | 11.67% | 14.66% | 17.20% |
| Indice di Sharpe | 0.97 | 1.91 | 0.30 | -0.19 | 0.42 |
| Mese migliore | +5.77% | +9.26% | +9.26% | +9.26% | +12.16% |
| Mese peggiore | -3.34% | -3.34% | -6.32% | -10.46% | -10.46% |
| Perdita massima | -6.73% | -6.73% | -15.24% | -24.42% | -24.42% |
| Outperformance | +16.58% | - | +23.21% | - | - |
Tutte le quotazioni in USD
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,327.7200 | +7.13% | +2.78% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,487.4099 | +7.27% | +3.16% | |
| Candriam Equities L Oncology Imp... | reinvestment | 201.4000 | +3.58% | -7.84% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,171.4199 | +4.03% | +13.26% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,562.0000 | +6.79% | +1.79% | |
| Candriam Equities L Oncology Imp... | reinvestment | 238.4900 | +4.68% | +11.78% | |
| Candriam Equities L Oncology Imp... | paying dividend | 228.9800 | +5.79% | -1.02% | |
| Candriam Equities L Oncology Imp... | paying dividend | 185.4600 | +6.69% | +1.50% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,122.0000 | +2.19% | -0.84% | |
| Candriam Equities L Oncology Imp... | reinvestment | 153.6200 | +3.91% | +12.88% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,048.2900 | +4.57% | -5.20% | |
| Candriam Equities L Oncology Imp... | reinvestment | 252.7600 | +5.57% | +14.64% | |
| Candriam Equities L Oncology Imp... | reinvestment | 200.8800 | +3.17% | -8.91% | |
| Candriam Equities L Oncology Imp... | reinvestment | 278.1000 | +6.68% | +1.49% | |
| Candriam Equities L Oncology Imp... | reinvestment | 188.1200 | +4.45% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,791.2200 | +4.36% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,795.8799 | +6.79% | +1.79% | |
| Candriam Equities L Oncology Imp... | reinvestment | 153.3100 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 266.0300 | +5.79% | -1.04% |
Prestazione
| YTD | +5.57% | ||
|---|---|---|---|
| 6 mesi | +11.66% | ||
| 1 anno | +7.27% | ||
| 3 anni | +3.16% | ||
| 5 anni | +69.07% | ||
| 10 anni | - | ||
| Dall'inizio | +65.10% | ||
| Anno | |||
| 2023 | +1.56% | ||
| 2022 | -9.27% | ||
| 2021 | +3.90% | ||
| 2020 | +33.03% | ||
